Author:
Boran M.,Doruk E.,Gönenç F.,Çetin S.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Coburn, J. W., Llach, F.: In: Drucker, W., Parsons, F. M., Maher, C. F., (eds): Renal Osteodystrophy and Maintenance Dialysis in Replacement of Renal Function by Dialysis. Martinus Nijhoff, Dordrecht 1990, p. 679.
2. Ahmet, K. Y., Varghesse, Z., Wills, M. R.: Long-term effect of small doses of 1.25 (OH)2 cholecalciferol in renal osteodystrophyLancet, 1, 629 (1978).
3. Madsen, S., Olgoard, K.: Long-term trail of 1 alfa hydroxycholecalciferol in adults with chronic failure,Eur. J. Clin. Pharmacol., 13, 401 (1970).
4. Cherrard, D. J., Coburn, J. W., Brickman, A. S.: Skeletal response to treatment with 1.25 (OH)2 cholecalciferol in renal failure.Contrib. Nephrol., 18, 92 (1980).
5. Cantley, L. K., Russel, K. J., Lettieri, D.: 1.25 (OH)2 cholecalciferol suppresses parathyroid hormone secretion from parathyroid cells in tissue culture.Endocrinology, 117, 2114 (1975).